Elevian
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $28M
Investors
- 8
About Elevian
Elevian, Inc.Founded in 2017 in the US, Elevian, Inc. specializes in biotherapeutics aimed at stroke recovery.25 mn.Elevian's core product offering, rGDF11, is a recombinant protein designed to facilitate recovery from ischemic and hemorrhagic strokes.Elevian's revenue model is driven by partnerships with healthcare institutions and potential pharmaceutical partners, primarily through licensing agreements and joint ventures.72 mn in September 2021, Elevian, Inc. is focused on advancing treatments for stroke recovery and age-related diseases. The company is exploring new product developments and aims to expand its market presence in North America and Europe by 2023.
Who invested in Elevian
8 investors across 2 rounds
See all investors in Elevian
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elevian
Who invested in Elevian?
Elevian has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elevian raised?
Elevian has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Elevian last raise money?
Elevian's most recent round on record is a Series A, in Sep 2021.
What does Elevian do?
Elevian is a biotechnology company.
Where is Elevian headquartered?
Elevian is headquartered in US.
Which VCs invest in companies like Elevian?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elevian's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Elevian? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.